Delcath Systems Inc. (DCTH)
Last updated: 2026-10-20 19:53:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Delcath Systems Inc. (DCTH) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $14.77, with a market capitalization of $488.56M and a P/E ratio of 937.26. Over the past 52 weeks, its price has ranged from $8.12 to $17.42. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$488.56M | |
$14.46 | |
$801,248,000,000.00 | |
$2.25 | |
$14.37 | |
209.88K | |
473.80K | |
937.26 | |
$17.42 | |
$8.12 | |
-- | |
-- |
Delcath Systems Inc. (DCTH) Stock Price Today
Delcath Systems Inc. (DCTH) is currently trading at $14.77 as of 2026-10-20 19:51:00, up 2.76% ($0.40) from the previous close of $14.37
During today's regular trading session, DCTH has traded between $2.25 and $801,248,000,000.00, with a trading volume of 209.88K shares. The current price is near the lower end of today's range.
Delcath Systems Inc. (DCTH) 7-Day Stock Price Change
Over the past seven days, Delcath Systems Inc. (DCTH) moved from $15.36 to $14.77, representing a decline of 3.87% ($0.59).
The stock traded between $14.00 and $15.77 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 254.28 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
DCTH 52-Week Price Position
Position in Range: 71.5%
DCTH is currently trading at $14.77, placing it 71.5% of the way from its 52-week low of $8.12 to its 52-week high of $17.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Delcath Systems Inc. (DCTH)?
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Delcath Systems Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 156 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Delcath Systems Inc. (DCTH) Stock on MEXC
Eligible investors can buy real shares of Delcath Systems Inc. (DCTH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Delcath Systems Inc. (DCTH) stock price today?
2.Is DCTH stock going up or down today?
3.What is DCTH pre-market price?
4.What is DCTH after-hours price?
5.Is DCTH stock trading now?
6.Where does DCTH sit relative to its 52-week high and low?
7.What sector is Delcath Systems Inc. in?
8.What is Delcath Systems Inc.'s market capitalization and where is it listed?
9.How is DCTH valued in terms of P/E ratio and EPS?
10.Does Delcath Systems Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DCTH Stock Calculator
Estimate the value between DCTH shares and USD.
DCTH Shares to USD
1.00 DCTH shares = 14.766 USD
Calculations are estimates based on the latest available price and are for reference only.



